KPC Pharmaceuticals Inc (600422) — Net Asset Quality Index
KPC Pharmaceuticals Inc (600422) has a Net Asset Quality Index of 58.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.98 Billion minus total liabilities of CN¥4.54 Billion yields net assets of CN¥6.44 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 600422 current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
KPC Pharmaceuticals Inc Net Asset Quality Index Over Time (1997–2025)
This chart shows how KPC Pharmaceuticals Inc's Net Asset Quality Index has evolved across 29 annual periods from 1997 to 2025. As of June 2026, the index stands at 58.6%, representing net assets of CN¥6.44 Billion against total assets of CN¥10.98 Billion CNY. For live market cap and overall valuation, see 600422 stock market capitalisation.
Annual Net Asset Quality Index for KPC Pharmaceuticals Inc (1997–2025)
The table below presents the year-by-year Net Asset Quality Index for KPC Pharmaceuticals Inc from 1997 to 2025, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of KPC Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 59.0% | CN¥6.94 Billion | CN¥11.77 Billion | CN¥4.83 Billion | ▲ +5.5 pp |
| 2024 | 53.5% | CN¥6.75 Billion | CN¥12.61 Billion | CN¥5.87 Billion | ▼ -11.2 pp |
| 2023 | 64.7% | CN¥7.95 Billion | CN¥12.30 Billion | CN¥4.34 Billion | ▲ +10.2 pp |
| 2022 | 54.5% | CN¥5.14 Billion | CN¥9.43 Billion | CN¥4.29 Billion | ▼ -1.0 pp |
| 2021 | 55.6% | CN¥4.94 Billion | CN¥8.89 Billion | CN¥3.95 Billion | ▼ -1.1 pp |
| 2020 | 56.7% | CN¥4.60 Billion | CN¥8.12 Billion | CN¥3.52 Billion | ▼ -1.6 pp |
| 2019 | 58.3% | CN¥4.33 Billion | CN¥7.43 Billion | CN¥3.10 Billion | ▲ +1.0 pp |
| 2018 | 57.3% | CN¥3.95 Billion | CN¥6.89 Billion | CN¥2.94 Billion | ▼ -2.2 pp |
| 2017 | 59.5% | CN¥3.77 Billion | CN¥6.34 Billion | CN¥2.56 Billion | ▼ -7.3 pp |
| 2016 | 66.9% | CN¥3.61 Billion | CN¥5.40 Billion | CN¥1.79 Billion | ▼ -0.6 pp |
| 2015 | 67.4% | CN¥3.34 Billion | CN¥4.95 Billion | CN¥1.61 Billion | ▼ -0.4 pp |
| 2014 | 67.8% | CN¥2.05 Billion | CN¥3.02 Billion | CN¥974.40 Million | ▲ +2.7 pp |
| 2013 | 65.1% | CN¥1.88 Billion | CN¥2.89 Billion | CN¥1.01 Billion | ▲ +16.0 pp |
| 2012 | 49.1% | CN¥1.06 Billion | CN¥2.15 Billion | CN¥1.10 Billion | ▼ -7.2 pp |
| 2011 | 56.3% | CN¥917.52 Million | CN¥1.63 Billion | CN¥712.37 Million | ▼ -1.6 pp |
| 2010 | 57.9% | CN¥820.15 Million | CN¥1.42 Billion | CN¥595.84 Million | ▼ -1.4 pp |
| 2009 | 59.3% | CN¥738.35 Million | CN¥1.24 Billion | CN¥505.79 Million | ▲ +1.4 pp |
| 2008 | 58.0% | CN¥670.50 Million | CN¥1.16 Billion | CN¥486.48 Million | ▲ +4.6 pp |
| 2007 | 53.4% | CN¥635.17 Million | CN¥1.19 Billion | CN¥554.98 Million | ▲ +1.6 pp |
| 2006 | 51.7% | CN¥583.86 Million | CN¥1.13 Billion | CN¥544.44 Million | ▲ +4.3 pp |
| 2005 | 47.5% | CN¥588.02 Million | CN¥1.24 Billion | CN¥650.31 Million | ▼ -14.2 pp |
| 2004 | 61.7% | CN¥723.20 Million | CN¥1.17 Billion | CN¥448.75 Million | ▼ -8.0 pp |
| 2003 | 69.7% | CN¥659.95 Million | CN¥946.71 Million | CN¥286.76 Million | ▼ -5.1 pp |
| 2002 | 74.8% | CN¥571.17 Million | CN¥763.28 Million | CN¥192.11 Million | ▲ +1.6 pp |
| 2001 | 73.3% | CN¥559.74 Million | CN¥763.98 Million | CN¥204.24 Million | ▲ +3.5 pp |
| 2000 | 69.8% | CN¥557.64 Million | CN¥798.80 Million | CN¥241.15 Million | ▲ +37.4 pp |
| 1999 | 32.4% | CN¥140.93 Million | CN¥435.12 Million | CN¥294.19 Million | ▼ -2.2 pp |
| 1998 | 34.6% | CN¥140.38 Million | CN¥405.44 Million | CN¥265.06 Million | ▼ -8.8 pp |
| 1997 | 43.4% | CN¥132.10 Million | CN¥304.23 Million | CN¥172.13 Million | — |